Dr. Mel Chua: Evolution of ChemoRT Trials in Nasopharyngeal Carcinoma: A Hobbit's Journey Part
1 意见
• 07/12/23
0
0
嵌入
In this second part of his lecture, Dr. Chua discusses ongoing trials in NPC, the significance of EBV titers and implications of the EBV vaccine, and his recently published trial in oligometastic NPC, among other topics.
显示更多
脸书评论
SORT BY-
热门评论
-
最新评论